SUSAN JULIUSSON: Open Payments
NPI 1033362892 · MADISON, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,944 in 54 payments from 29 companies in 2025. Trend: 2023 $3,585 · 2024 $2,018 · 2025 $1,944
Food & beverage: $1,944
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $398 |
| Gilead Sciences, Inc. | 4 | $396 |
| Tempus AI, Inc | 3 | $184 |
| Daiichi Sankyo Inc. | 8 | $142 |
| Amgen Inc. | 1 | $125 |
| Exelixis Inc. | 3 | $85 |
| GlaxoSmithKline, LLC. | 3 | $78 |
| Ipsen Biopharmaceuticals, Inc | 2 | $59 |
| Janssen Biotech, Inc. | 2 | $56 |
| Lilly USA, LLC | 2 | $39 |
Products named: ENHERTU, XT CDX, CALQUENCE, Trodelvy, IMDELLTRA (AMG757), CABOMETYX, TAGRISSO, REBLOZYL.
Industry payments across WI — which companies pay providers there.
